AtriCure (ATRC) Misses Q4 EPS by 1c

AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.39 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS